Cyfuse Biomedical

BiotechnologySeries CTokyo, Japancyfusebio.com

Latest round

Series C

Last raised

Nov 2017

Total raised

$28M

Investors

18

About Cyfuse Biomedical

Cyfuse Biomedical Inc. is a Japan-based company that develops 3D cellular constructs for the regeneration of blood vessels, bones and cartilage, and peripheral nerves with its bio 3D fabrication technology.

Who invested in Cyfuse Biomedical

18 investors across 4 rounds

See all investors in Cyfuse Biomedical

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Nov 24, 2017

    Amount

    $9.8M

    Investors

    Locked

  2. Series B

    Mar 2, 2015

    Amount

    $12M

    Investors

    Locked

  3. Series A

    May 17, 2013

    Amount

    $1.5M

    Investors

    Locked

  4. Series A

    Jan 23, 2013

    Amount

    $4.8M

    Investors

    Locked

Questions about Cyfuse Biomedical

Who invested in Cyfuse Biomedical?

Cyfuse Biomedical has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cyfuse Biomedical raised?

Cyfuse Biomedical has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Cyfuse Biomedical last raise money?

Cyfuse Biomedical's most recent round on record is a Series C, in Nov 2017.

What does Cyfuse Biomedical do?

Cyfuse Biomedical is a biotechnology company.

Where is Cyfuse Biomedical headquartered?

Cyfuse Biomedical is headquartered in Tokyo, Japan.

Which VCs invest in companies like Cyfuse Biomedical?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Cyfuse Biomedical's stage. Their profiles are linked below.

Raising like Cyfuse Biomedical? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.